Science & Enterprise subscription

Follow us on Twitter

  • Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences li… https://t.co/WGboSsrf7U
    about 15 hours ago
  • New post on Science and Enterprise: Gene Therapy Company Exploring DNA Circuit Technology https://t.co/2YUM4DVZRK #Science #Business
    about 15 hours ago
  • A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects again… https://t.co/3JtSqD1Sa2
    about 19 hours ago
  • New post on Science and Enterprise: Vaccine Stops Lyme Bacteria in Preclinical Test https://t.co/7H0Lc90nRe #Science #Business
    about 19 hours ago
  • Stop the panic porn ... Coronavirus Variants Don’t Have to Be Scary. Still, Mask Up. https://t.co/d6aDu2Ucj6
    about 22 hours ago

Please share Science & Enterprise

Gene Therapy Company Exploring DNA Circuit Technology

Circuit graphic

Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits. . . . → Read More: Gene Therapy Company Exploring DNA Circuit Technology

Arthritis Drug Unsuccessful for Covid-19 Hospital Patients

Hospital room

A clinical trial shows a drug designed to reduce inflammation in autoimmune disease patients does not clearly help patients hospitalized with Covid-19 disease. . . . → Read More: Arthritis Drug Unsuccessful for Covid-19 Hospital Patients

Infectious Disease Biotech Raises $100M in Venture Funds

Syringe and three vials

A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds

Univ. Lab Develops, Licenses Sports Injury Implant

Pitcher Matt Grace

A medical device company now offers a synthetic tissue implant for torn rotator cuff, a common sports injury, designed at a Purdue University engineering lab. . . . → Read More: Univ. Lab Develops, Licenses Sports Injury Implant

Vaccine Spin-Off Raises $168 Million in New Funds

Syringes

A developer of vaccines, including a leading Covid-19 vaccine, and cancer immunotherapies, is raising $168 million in its second venture round. . . . → Read More: Vaccine Spin-Off Raises $168 Million in New Funds

New Covid-19 mRNA Vaccine Trial Begins

Syringe in hand

A clinical trial is underway testing a new Covid-19 vaccine based on messenger RNA, developed by biotech company Translate Bio and drug maker Sanofi. . . . → Read More: New Covid-19 mRNA Vaccine Trial Begins

Carb-X Funds Vaccine Against Resistant Staph Infections

MRSA bacteria

An international consortium is funding a vaccine to prevent increasingly resistant Staphylococcus aureus infections found in health care facilities. . . . → Read More: Carb-X Funds Vaccine Against Resistant Staph Infections

Multiple Solid-Tumor Immunotherapy Trial Underway

Cancer on clipboard

A clinical trial is underway testing an immunotherapy for several types of stubborn solid tumor cancer, based on research in university labs. . . . → Read More: Multiple Solid-Tumor Immunotherapy Trial Underway

Immune Response Shown in Alzheimer’s Vaccine

Brain activity graphic

Results from a clinical trial show an experimental vaccine produces antibodies for breaking up harmful brain deposits in people with early Alzheimer’s disease. . . . → Read More: Immune Response Shown in Alzheimer’s Vaccine

AbbVie Licenses Engineered Crispr Cell Process

Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies. . . . → Read More: AbbVie Licenses Engineered Crispr Cell Process